Discordance between Histopathological grading and Dual Tracer PET-CT findings ( < sup > 68 < /sup > Ga-DOTATATE and FDG) in metastatic Neuroendocrine Neoplasms and outcome of < sup > 177 < /sup > Lu-DOTATATE PRRT: does in-vivo molecular PET imaging perform better from 'prediction of tumour biology' viewpoint?

Conclusion: In summary, in NET patients with discordance between the two parameters, dual tracer PET-CT with FDG and 68Ga-DOTATATE performed better than WHO grading, differentiation status and immunohistochemistry in prognosticating and predicting outcome.PMID:34876476 | DOI:10.2967/jnmt.121.261998
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Authors: Source Type: research